{
    "2018-04-26": [
        [
            {
                "time": "",
                "original_text": "上海莱士血液制品股份有限公司利润分配政策及未来三年（2018-2020）股东回报规划",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "利润分配",
                        "股东回报",
                        "未来三年"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海莱士血液制品股份有限公司关于公司2017年证券投资情况的专项说明",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "证券投资",
                        "2017年"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}